Boehringer Ingelheim's expenditure on research and development 2004-2022
In 2022, the company invested just over five billion euros in research and development. The Boehringer Ingelheim group is one of the world's top 20 pharmaceutical companies. The company is headquartered in Ingelheim, Germany. This statistic describes the expenditure on research and development by pharmaceutical company Boehringer Ingelheim from 2004 to 2022.